ASND - Ascendis Pharma A/S

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.78B
Enterprise Value 32.31B
Trailing P/E N/A
Forward P/E 1-14.56
PEG Ratio (5 yr expected) 1-0.56
Price/Sales (ttm)3,137.02
Price/Book (mrq)7.18
Enterprise Value/Revenue 32,607.85
Enterprise Value/EBITDA 6-13.85

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018


Profit Margin 0.00%
Operating Margin (ttm)-18,938.16%

Management Effectiveness

Return on Assets (ttm)-35.19%
Return on Equity (ttm)-57.64%

Income Statement

Revenue (ttm)885.38k
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)-95.90%
Gross Profit (ttm)1.53M
EBITDA -166.76M
Net Income Avi to Common (ttm)-154.01M
Diluted EPS (ttm)-4.11
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)410.77M
Total Cash Per Share (mrq)9.82
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)9.87
Book Value Per Share (mrq)9.25

Cash Flow Statement

Operating Cash Flow (ttm)-124.4M
Levered Free Cash Flow (ttm)-65.23M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.72
52-Week Change 397.75%
S&P500 52-Week Change 37.27%
52 Week High 376.99
52 Week Low 331.56
50-Day Moving Average 366.26
200-Day Moving Average 367.24

Share Statistics

Avg Vol (3 month) 3113.92k
Avg Vol (10 day) 3110.08k
Shares Outstanding 541.84M
Float 22.08M
% Held by Insiders 124.14%
% Held by Institutions 147.07%
Shares Short (Sep 28, 2018) 4376.75k
Short Ratio (Sep 28, 2018) 42.99
Short % of Float (Sep 28, 2018) 4N/A
Short % of Shares Outstanding (Sep 28, 2018) 40.94%
Shares Short (prior month Aug 31, 2018) 4343.06k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A